Skip to content
10-Q

Quarterly Report

ATYR PHARMA, INC. ATYR

0001339970-25-000009

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 97.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 90.12M sh
Shares Diluted Q2 2025 · Jun 30, 2025 88.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 72.28M sh
Shares Diluted Q2 2025 · Jun 30, 2024 69.2M sh
Capex Q2 2025 · Jun 30, 2025 $9K
Capex Q2 2025 · Jun 30, 2024 $25K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$29.31M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$42.83M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $17.22M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $11.06M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $6.81M
Stockholders Equity Q2 2025 · Jun 30, 2025 $74.85M
Stockholders Equity Q2 2025 · Dec 31, 2024 $70.02M
Current Liabilities Q2 2025 · Jun 30, 2025 $15.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $14.97M
Current Assets Q2 2025 · Jun 30, 2025 $87.49M
Current Assets Q2 2025 · Dec 31, 2024 $81.95M
Total Assets Q2 2025 · Jun 30, 2025 $101.53M
Total Assets Q2 2025 · Dec 31, 2024 $96.83M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.22
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.39
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.23
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.46
Eps Basic Q2 2025 · Jun 30, 2025 −$0.22
Eps Basic Q2 2025 · Jun 30, 2025 −$0.39
Eps Basic Q2 2025 · Jun 30, 2024 −$0.23
Eps Basic Q2 2025 · Jun 30, 2024 −$0.46
Sga Expense Q2 2025 · Jun 30, 2025 $4.93M
Sga Expense Q2 2025 · Jun 30, 2025 $8.89M
Sga Expense Q2 2025 · Jun 30, 2024 $3.34M
Sga Expense Q2 2025 · Jun 30, 2024 $6.85M
Rd Expense Q2 2025 · Jun 30, 2025 $15.38M
Rd Expense Q2 2025 · Jun 30, 2025 $27.2M
Rd Expense Q2 2025 · Jun 30, 2024 $13.97M
Rd Expense Q2 2025 · Jun 30, 2024 $27.34M
Net Income Q2 2025 · Jun 30, 2025 −$19.53M
Net Income Q2 2025 · Jun 30, 2025 −$34.41M
Net Income Q2 2025 · Jun 30, 2024 −$16.31M
Net Income Q2 2025 · Jun 30, 2024 −$31.8M
Operating Income Q2 2025 · Jun 30, 2025 −$20.31M
Operating Income Q2 2025 · Jun 30, 2025 −$36.09M
Operating Income Q2 2025 · Jun 30, 2024 −$17.32M
Operating Income Q2 2025 · Jun 30, 2024 −$33.95M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $235K